The purpose of this study is to evaluate the efficacy of DSG 1% compared with placebo applied four times a day in subjects with acute blunt soft tissue injuries/contusions of the limbs
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
204
Topical gel 1%- 4 times daily
Topical gel - 4 times daily
NCH investigative site
Brühl, Germany
NCH investigative site
Butzbach, Germany
NCH investigative site
Cologne, Germany
NCH investigative site
Essen, Germany
NCH investigative site
Pain on Movement
Visual analog scale (VAS) assessed on a 100 mm scale with anchors at 0= "No pain" and 100= "Extreme pain"
Time frame: VAS Score at 24 hours
Onset of Pain Relief
Onset of perceptible pain relief.
Time frame: From randomization to end of day 1
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Gilching, Germany
NCH investigative site
Munich, Germany